#$%^&*AU2017203897A120170629.pdf#####1: \dar\Interwovn\NRPortbl\DCC\DAR\14683177_i.docx-5 06 2017 Abstract Orally administerable deferasirox formulations are disclosed having reduced release under gastric conditions and fast release at near neutral pH or at neutral pH.